Compare AbCellera Biologics Inc (ABCL) vs Kaltura Inc (KLTR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
AbCellera Biologics Inc vs Kaltura Inc — how do they compare? AbCellera Biologics Inc trades at $9.03 (market cap $2.99B), while Kaltura Inc trades at $1.63 (market cap $249.42M). The key difference: AbCellera Biologics Inc is far larger — about 12× Kaltura Inc's market cap, and AbCellera Biologics Inc is trading nearer its 52-week high, Kaltura Inc nearer its low. Which is the better fit depends on your goals.
| ABCL | KLTR | |
|---|---|---|
Market Cap | $2.99B | $249.42M |
Sector | Health | Technology |
52-Week High | $9.76 | $1.89 |
52-Week Low | $2.78 | $1.08 |
Enterprise Value | $2.58B | $261.64M |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About AbCellera Biologics Inc
AbCellera Biologics Inc is a biotechnology company. It develops antibodies to treat infectious diseases and various other types of diseases. The company's AI-powered technology sources, searches, decodes and analyzes antibody responses to engineer new antibody drug candidates for its partners.
Read more on ABCL →About Kaltura Inc
Kaltura Inc provides live and on-demand video SaaS solutions to thousands of organizations around the world, engaging hundreds of millions of viewers at home, at work, and school. It also offers specialized industry solutions, including Learning Management System Video, Lecture Capture, and Virtual Classroom for educational institutions, as well as a TV Solution for media and telecom companies. It operates in two reporting segments: (i) Enterprise, Education, and Technology (EE&T)
Read more on KLTR →
